EXHANCE-3: A Phase 3, Three-Month Study of Safety and Efficacy of Fluticasone Propionate Exhalation Delivery System (FLU-EDS) in Patients With Chronic Rhinosinusitis With (CRSwNP) and Without Nasal Polyps (CRSsNP)
Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2016.12.261
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2017
Authors
Publisher
Elsevier BV